We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Wearable Sensor Patch Continuously Monitors ‘Last Line of Defense’ Antibiotic with Less Pain than Blood Draw

By HospiMedica International staff writers
Posted on 04 Oct 2023

Since the first use of penicillin in 1928, bacteria have continually evolved, finding ways to resist or entirely evade the effects of antibiotics. More...

However, medical professionals still have a reserve of seldom-used antibiotics that work against these resistant bacteria strains. Now, a team of researchers has combined its earlier research on painless microneedles with nanoscale sensors to develop a wearable patch that can continuously monitor the levels of one such antibiotic.

Researchers at Sandia National Laboratories (Albuquerque, NM, USA) have focused on an antibiotic named vancomycin, which is considered a last-resort treatment for treating severe bacterial infections. Continuous monitoring is crucial for vancomycin, as it has a narrow range within which it can kill bacteria without harming the patient. The team used sensors known as aptamers, which are DNA strands featuring a surface linker on one end and an electrically sensitive chemical on the other. When these DNA strands attach to vancomycin, they change shape, pulling the electrically sensitive chemical closer to the gold surface, causing a detectable change in electrical current. When there is a reduction in the vancomycin concentration, some DNA regain its original shape, which is also detected electrically

After building these microneedle sensors, the researchers first tested their ability to detect vancomycin in a saline solution, simulating the conditions within the human body. Once confirmed, they then ran tests in a far more complex medium: pure cow's blood, where the system remained effective. Subsequently, they conducted experiments inserting the sensor patch into pig skin multiple times to examine both the electronic signal and its capability to detect vancomycin. Following the successful results, they now aim to fully test the sensor patch system in humans or other animals.

In the future, a similar setup using different DNA aptamers could be employed for monitoring cytokines—tiny proteins that transmit signals inside the body—and other molecules whose levels fluctuate during infections. This technology could enable quicker diagnoses and even aid in emergency triage. The team has also been investigating potential elements in blood and skin that could impede the sensor's precision. They discovered that fibrinogen, a protein vital to blood clotting, can interfere with the sensor's signals.

“This is a great application because it requires tight control,” said Philip Miller, a Sandia biomedical engineer who advised on the project. “In a clinical setting, how that would happen is a doctor would check on the patient on an hourly basis and request a single time-point blood measurement of vancomycin. Someone would come to draw blood, send it to the clinic and get an answer back at some later time. Our system is one way to address that delay.”

Related Links:
Sandia National Laboratories


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Mattress System
Apollo Infant Dynamic
New
Critical Care Cart
Avalo
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.